Moderna's Omicron-specific booster could start clinical trials early next year

Moderna's Omicron-specific booster could start clinical trials early next year Biotechnology company Moderna continues to work on developing Covid-19 boosters that specifically target certain variants, including Delta and Omicron, Dr. Stephen Hoge, president of the company, said Monday. By Jack Guy and Aditi Sangal CNN

...

For now, Moderna plans to focus its "immediate efforts" around Omicron on advancing the current vaccine that is already available, Hoge said.